{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:14:09Z","timestamp":1763705649500,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.prp.2019.152520","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T12:17:13Z","timestamp":1561637833000},"page":"152520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer"],"prefix":"10.1016","volume":"215","author":[{"given":"Hui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2019.152520_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.04.016","article-title":"Incidence and mortality of gynaecological cancers: secular trends in urban Shanghai, China over 40 years","volume":"63","author":"Huang","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.prp.2019.152520_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ygyno.2017.10.001","article-title":"Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction","volume":"147","author":"Jones","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2019.152520_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1158\/1055-9965.EPI-17-0315","article-title":"Common genetic variation and susceptibility to ovarian cancer: current insights and future directions","volume":"27","author":"Kar","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5","key":"10.1016\/j.prp.2019.152520_bib0020","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1158\/1055-9965.EPI-12-1030-T","article-title":"Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer","volume":"22","author":"Pearce","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"5573","key":"10.1016\/j.prp.2019.152520_bib0025","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.prp.2019.152520_bib0030","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.1007\/s13277-016-4924-2","article-title":"Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer","volume":"37","author":"Dirican","year":"2016","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.prp.2019.152520_bib0035","first-page":"2243","article-title":"PIK3CA mutations detected in patients with central nervous system metastases of non-small cell lung cancer","volume":"36","author":"Nicos","year":"2016","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2019.152520_bib0040","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2147\/OTT.S97668","article-title":"Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer","volume":"9","author":"He","year":"2016","journal-title":"Onco. Ther."},{"issue":"3","key":"10.1016\/j.prp.2019.152520_bib0045","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2016.07.092","article-title":"Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genes","volume":"142","author":"Wang","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2019.152520_bib0050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrd2926","article-title":"Targeting the phosphoinositide 3-kinase pathway in cancer","volume":"8","author":"Liu","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.prp.2019.152520_bib0055","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrd4204","article-title":"PI3K and cancer: lessons, challenges and opportunities","volume":"13","author":"Fruman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.prp.2019.152520_bib0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.prp.2019.152520_bib0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijgo.2007.11.004","article-title":"History of the FIGO cancer staging system","volume":"101","author":"Odicino","year":"2008","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"3","key":"10.1016\/j.prp.2019.152520_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003212","article-title":"Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk","volume":"9","author":"Couch","year":"2013","journal-title":"PLoS Genet."},{"issue":"8","key":"10.1016\/j.prp.2019.152520_bib0075","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/gepi.21921","article-title":"Epithelial-mesenchymal transition (EMT) gene variants and epithelial ovarian cancer (EOC) risk","volume":"39","author":"Amankwah","year":"2015","journal-title":"Genet. Epidemiol."},{"issue":"7","key":"10.1016\/j.prp.2019.152520_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158801","article-title":"Fine-scale mapping at 9p22.2 identifies candidate causal variants that modify ovarian cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"11","author":"Vigorito","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.prp.2019.152520_bib0085","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1158\/1078-0432.CCR-04-2142","article-title":"Frequent mutation of the PIK3CA gene in ovarian and breast cancers","volume":"11","author":"Levine","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2019.152520_bib0090","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and promise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2019.152520_bib0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2017.02.037","article-title":"PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials","volume":"175","author":"Dey","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"43","key":"10.1016\/j.prp.2019.152520_bib0100","doi-asserted-by":"crossref","first-page":"27220","DOI":"10.18632\/oncotarget.25513","article-title":"Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistance","volume":"9","author":"Le Naour","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2019.152520_bib0105","doi-asserted-by":"crossref","first-page":"12799","DOI":"10.1038\/ncomms12799","article-title":"Anks1a regulates COPII-mediated anterograde transport of receptor tyrosine kinases critical for tumorigenesis","volume":"7","author":"Lee","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.prp.2019.152520_bib0110","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/liv.13055","article-title":"Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2\/mTORC1 cascade","volume":"36","author":"Wang","year":"2016","journal-title":"Liver Int."},{"issue":"23","key":"10.1016\/j.prp.2019.152520_bib0115","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1038\/onc.2015.377","article-title":"PIK3CA(H1047R)- and Her2-initiated mammary tumors escape PI3K dependency by compensatory activation of MEK-ERK signaling","volume":"35","author":"Cheng","year":"2016","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.prp.2019.152520_bib0120","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00280-018-3543-6","article-title":"Phosphorylation of AKT and ERK1\/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro","volume":"81","author":"Citi","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"22","key":"10.1016\/j.prp.2019.152520_bib0125","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1158\/1078-0432.CCR-13-1093","article-title":"Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer","volume":"19","author":"Li","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2019.152520_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/cbt.8.1.7209","article-title":"PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients","volume":"8","author":"Kolasa","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"Pt 5","key":"10.1016\/j.prp.2019.152520_bib0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1242\/jcs.013029","article-title":"Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer","volume":"121","author":"Astanehe","year":"2008","journal-title":"J. Cell. Sci."},{"issue":"5","key":"10.1016\/j.prp.2019.152520_bib0140","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1158\/1055-9965.EPI-15-1039","article-title":"Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors","volume":"25","author":"Usset","year":"2016","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819300810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819300810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:37:36Z","timestamp":1759732656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819300810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0344033819300810"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152520","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152520","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152520"}}